CD80 and neoplasm: Simultaneously, it stimulated DCs and macrophages to express more CD80/86 co-stimulatory molecules and produce more interleukin-12 (IL-12) (Baird et al., 2013a), thus countering the immunosuppressive environment around tumor cells and triggering a range of anti-tumor immune responses.